FUTURA MEDICAL PLC

Futura Medical’s share price dips to a 25% discount of its 200‑day SMA, offering a niche‑focused, regulated pipeline in sexual‑health for long‑term investors.

Futura Medical’s stock crashes 9.55% as investors question its niche sexual‑health focus and lack of revenue, spotlighting the risks of small‑cap biotech speculation.